Search

everythinglearnresearchcommunity

for

Search:↓

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Omega-6 fats in certain cells boost male hormone production.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Short photoperiods improve cashmere growth and quality in goats by changing hormone levels and gene expression.

The conclusion is that certain chemicals from Bacillus subtilis help improve plant root growth through a hormone-related process.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Thyroid hormone receptors are essential for hair growth and wound healing.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Caffeine may help reduce stress-induced hair loss.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.